231 filings
Page 3 of 12
8-K
76csszynvdk
14 Nov 22
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
4:05pm
8-K
k11izfq9
15 Aug 22
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
4:20pm
8-K
egwgvx8u0nnwslp8uq
12 Aug 22
Other Events
4:57pm
424B5
uty i4pa9i0ztlb1
12 Aug 22
Prospectus supplement for primary offering
4:46pm
8-A12B
wlur9xq0om ub
12 Jul 22
Registration of securities on exchange
9:21am
8-K
zaaos4 zx
12 Jul 22
Entry into a Material Definitive Agreement
9:12am
S-8
pjnv esknq9ix
24 Jun 22
Registration of securities for employees
4:06pm
8-K
a69vimvej72wn0py44
7 Jun 22
Forte Biosciences, Inc. Announces the Appointment of
9:03am
8-K
0gob4ne1ep1h0t
2 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
t1o fj996bs6
19 May 22
Additional proxy soliciting materials
4:05pm
8-K
750mm zsy
16 May 22
Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update
9:01am
8-K
560exj
31 Mar 22
Entry into a Material Definitive Agreement
8:57pm
424B5
o6nao2 ggrjyxc
31 Mar 22
Prospectus supplement for primary offering
8:55pm
8-K
3ykj7xw4h
18 Mar 22
Departure of Directors or Certain Officers
9:01am
8-K
nzlg dfrursrkuzapmtx
2 Feb 22
Termination of a Material Definitive Agreement
4:35pm